The investigational fungal Cyp51 inhibitor VT-1129 demonstrates potent in vitro activity against cryptococcus neoformans and cryptococcus gattii

  • Shawn R. Lockhart
  • , Annette W. Fothergill
  • , Naureen Iqbal
  • , Carol B. Bolden
  • , Nina T. Grossman
  • , Edward P. Garvey
  • , Stephen R. Brand
  • , William J. Hoekstra
  • , Robert J. Schotzinger
  • , Elizabeth Ottinger
  • , Thomas F. Patterson
  • , Nathan P. Wiederhold

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The investigational fungal Cyp51 inhibitor VT-1129 demonstrates potent in vitro activity against cryptococcus neoformans and cryptococcus gattii'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science